Orthopaedic Industry News & Orthopaedic Company News | Orthogate Professionals

In order to use Medscape, your browser must be set to accept cookies delivered by the Medscape site.

Medscape uses cookies to customize the site based on the information we collect at registration. The cookies contain no personally identifiable information and have no effect once you leave the Medscape site.

According to market research “Global Biomaterial Market Size, Share, Development, Growth and Demand Forecast to 2022– Industry Insights by Material (Metallic, Polymer, Ceramic, and Others), by Application (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Ophthalmology, Neurological Condition and Others)” by P&S Market Research, the global biomaterial market was valued at $62,068.0 million in 2015 and it is expected to grow at a CAGR of 16.1% during 2016-2022. The polymer biomaterial segment in the global biomaterial market is expected to witness the fastest growth, a CAGR of 19.8% during the forecast period.

     (Logo: http://photos.prnewswire.com/prnh/20150727/756778 )

Access Report Description with Detailed TOC on“GlobalBiomaterialMarket” at: https://www.psmarketresearch.com/market-analysis/biomaterials-market

By Chris Fitzpatrick
In November 2007, Google released Android as an operating system (OS), targeted primarily at smart phones. Since then, we have witnessed its phenomenal success. It is now the most popular OS for smart phones in the world.
While most industries have leveraged Android in various ways, the healthcare industry has lagged behind. This is not entirely surprising because, generally speaking, the healthcare industry is slow in adopting new technologies such as this. A reason is the highly regulated nature of the industry, which leads to a tendency to wait for a technology to mature before adopting it. But in the past few years, interest and adoption of Android as the operating system (OS) for medical devices development has grown dramatically.

PIERCETON -

Kosciusko County-based Paragon Medical Inc. is marking a milestone anniversary. After 25 years, the orthopaedic industry contract manufacturer has a global presence with centers in Switzerland, China and Poland and two Indiana locations.

Its domestic facilities are in Pierceton (headquarters), Indianapolis and Utah. The company started as a polymer product manufacturer and soon spread in the medical device industry, producing custom surgical instruments, metal and hybrid cases and tray sets, as well as offering integrated manufacturing support capabilities.

Chief Executive Officer Tobias Buck says "we are deeply appreciative of the hard work of our employees and the contribution they have made over the last quarter of a century.

The FDA’s Orthopaedic and Rehabilitation Devices Panel will meet on April 20, 2016 to discuss, make recommendations, and vote on the premarket approval application (PMA) for the Cartiva Synthetic Cartilage Implant (SCI), sponsored by Cartiva, Inc.

Cartiva’s implant is an organic polymer-based biomaterial to mimic biologic cartilage. The device, according to an FDA announcement, is to be indicated for treatment of degenerative and post-traumatic arthritis in the first metatarsophalangeal joint in the presence of good bone stock along with the following clinical conditions: hallux valgus or hallux limitus, hallux rigidus, and an unstable or painful metatarsophalangeal joint.

The FDA intends to make background material available to the public no later than two business days before the meeting.

Albany, NY -- (SBWIRE) -- 03/11/2016 -- Description

Old people have trouble making their joints last as long as they do. The patient stability and the relief from pain provided by the implant is compelling. The major suppliers are providing implants that are state of the art. Orthopedic reconstructive implants are used to replace joints that have deteriorated. Deterioration may come as a result of aging, disease, osteoarthritis, or injury.

Total hip replacement surgery has evolved dramatically over the years as advances in technology have made it possible to improve surgical techniques. 325,000 people had total hip replacement surgery in 2015 in the United States.